Erythropoiesis-stimulating agents

10Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Erythropoiesis is the process whereby erythroid progenitor cells differentiate and divide, resulting in increased numbers of red blood cells (RBCs). RBCs contain hemoglobin, the main oxygen carrying component in blood. The large number of RBCs found in blood is required to support the prodigious consumption of oxygen by tissues as they undergo oxygen-dependent processes. Erythropoietin is a hormone that when it binds and activates Epo receptors resident on the surface of cells results in stimulation of erythropoiesis. Successful cloning of the EPO gene allowed for the first time production of recombinant human erythropoietin and other erythropoiesis stimulating agents (ESAs), which are used to treat anemia in patients. In this chapter, the control of Epo levels and erythropoiesis, the various forms of ESAs used commercially, and their physical and biological properties are discussed. © 2011 Springer Science+Business Media, LLC.

Cite

CITATION STYLE

APA

Elliott, S. (2011). Erythropoiesis-stimulating agents. Cancer Treatment and Research. https://doi.org/10.1007/978-1-4419-7073-2_4

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free